Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Hospitals & Diagnostics
    • Not impacted by Delhi...

    Not impacted by Delhi High Court order: Fortis Healthcare

    Written by Ruby Khatun Khatun Published On 2018-02-28T10:30:11+05:30  |  Updated On 28 Feb 2018 10:30 AM IST
    Not impacted by Delhi High Court order: Fortis Healthcare

    New Delhi: Fortis Healthcare and Religare Enterprises said they have not been impacted by the Delhi High Court order directing attachment of all debt-free assets of their promoters Singh brothers.


    The two companies in separate filings to the BSE said that they are not the party to the arbitration or ongoing proceedings in the Delhi High Court related to the Daiichi-Sankyo row.


    "... the company was not a party to the arbitration and /or is not a party to ongoing proceedings in the Delhi High Court and as such is not impacted by its outcome," Fortis Healthcare said in a filing to BSE.


    Also, the outcome of the proceeding does not have any material direct impact on the company or its operations, it added.


    Religare also said it is not a party to ongoing proceedings in the Delhi High Court and as such is not involved or impacted by its outcome.


    Further, the proceedings do not have any ad-interim or interim order passed against or in favour of the company, the filing said.


    Religare and Fortis Healthcare were responding to the clarification sought by the BSE with reference to media reports that said HC ordered attachment of Singh brothers' assets in Daiichi-Ranbaxy row.


    Shares of Fortis Healthcare today closed at Rs 155.70 per scrip on BSE, down 2.44 percent from the previous close. Religare Enterprises closed at Rs 57.95 per scrip on BSE, down 2.77 percent from its previous close.


    The Delhi High Court yesterday ordered the attachment of all unencumbered assets of two holding companies of former promoters of India's Ranbaxy Laboratories Ltd to execute the Rs 3,500 crore arbitral award won by Japanese pharma major Daiichi Sankyo.


    Justice Jayant Nath issued the warrants for attaching the unencumbered assets of RHC Holdings Pvt Ltd and Oscar Investments Pvt Ltd and directed former Ranbaxy promoters and brothers, Malvinder Singh and Shivinder Singh, and 10 others to file within 10 days a list of their unencumbered assets.


    Read also: Use Unpledged assets of Singh brothers to repay Daiichi’s award: HC
    Daiichi SankyoDelhi high courtFortisFortis HealthcareJustice Jayant NathMalvinder SinghOscar Investments Pvt LtdRanbaxy laboratoriesReligareReligare EnterprisesRHC Holdings Pvt LtdShivinder SinghSingh brothersunencumbered assets
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok